IHS Chemical Week

People & Business :: Companies

Lonza to Buy Stake in Indian Firm?

6:27 AM MDT | March 24, 2010 | Deepti Ramesh

Lonza is in discussions with pharmaceutical company Aptuit Laurus (Hyderabad, India), to acquire a majority stake in the Indian company, say press reports. The deal maybe valued at about Rs.3.5 billion-Rs.4.5 billion ($77 million-$99 million), reports add. Aptuit Laurus mainly produces active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals, and the company also provides various services including early-stage drug discovery, medicinal chemistry, drug product development and analytical services. Aptuit Laurus was formed in 2007 as a joint...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa